Related Experiment Video

Updated: Aug 15, 2026

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

[Prophylactic effectiveness of a live recombinant influenza type A vaccine in immunizing children aged 3-14 years]

L G Rudenko, R I Vasil'eva, A T Ismagulov

    Voprosy Virusologii
    |January 1, 1996
    PubMed

    Insights

    This study found live recombinant influenza A vaccine safe for children aged 3-14. It demonstrated efficacy against the A/Taiwan/1/86(H1N1) influenza virus.

    Area of Science:

    • Immunology
    • Vaccinology
    • Pediatric Infectious Diseases

    Context:

    • Influenza A poses a significant public health threat, particularly to children.
    • Live attenuated vaccines offer potential advantages in immunogenicity and ease of administration.
    • Evaluating novel vaccine platforms is crucial for enhancing influenza prevention strategies.

    Purpose:

    • To assess the safety and efficacy of a live recombinant influenza A vaccine in children.
    • To determine the protective index of the vaccine during an influenza A epidemic.

    Summary:

    • A 6-month study followed approximately 120,000 children aged 3 to 14 immunized with a live recombinant influenza A vaccine.
    • Morbidity analysis, excluding acute respiratory viral infections and influenza, indicated the vaccine's safety.
    • The vaccine demonstrated a protective index of 1.3 to 1.42 against the A/Taiwan/1/86(H1N1) influenza virus.

    Impact:

    • The live recombinant influenza A vaccine is recommended for public health use in children aged 3 to 14.
    • This finding supports the integration of novel influenza vaccines into pediatric immunization programs.
    • The study provides evidence for effective influenza prevention in a vulnerable pediatric population.

    More Related Videos

    An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers06:34

    An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

    Published on: December 1, 2017

    A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection05:21

    A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

    Published on: August 14, 2019

    Related Concept Videos

    Vaccinations01:51

    Vaccinations

    Overview
    Vaccines01:21

    Vaccines

    Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
    Smallpox01:24

    Smallpox

    Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
    Poliomyelitis01:17

    Poliomyelitis

    Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
    Influenza01:27

    Influenza

    Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
    Respiratory Syncytial Virus Disease01:29

    Respiratory Syncytial Virus Disease

    Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...